Our founder Ipsita Smolinski discussed early stage clinical research and other trends as it pertains to the Inflation Reduction Act. Small molecule vs large molecule investments, ADCs & bispecifics, as well as other R&D trends, particularly as it pertains to oncology, neuroscience, and cardiovascular diseases. Thank you to We Work For Health for the opportunity to discuss our work on the biopharma clinical and investment landscape Duane SchulthessAdina LasserDan Leonard
